Mendel Capital Management’s Eli Lilly LLY Stock Holding History

Mendel Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,031	Closed	-$933K	–	96
2024 Q2	$933K	Hold	1,031	–	–	0.6%	44
2024 Q1	$802K	Hold	1,031	–	–	0.53%	47
2023 Q4	$601K	Buy	1,031 +31	+3%	+$18.1K	0.43%	50
2023 Q3	$537K	Hold	1,000	–	–	0.44%	51
2023 Q2	$469K	Hold	1,000	–	–	0.38%	55
2023 Q1	$343K	Hold	1,000	–	–	0.31%	55
2022 Q4	$366K	Hold	1,000	–	–	0.38%	47
2022 Q3	$323K	Hold	1,000	–	–	0.38%	49
2022 Q2	$324K	Hold	1,000	–	–	0.36%	50
2022 Q1	$286K	Hold	1,000	–	–	0.27%	58
2021 Q4	$276K	Buy	+1,000	New	+$254K	0.25%	57

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Mendel Capital Management's LLY Position: Q3 2024 in Review

Mendel Capital Management sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 1,031 shares — an estimated $933K sold.

Mendel Capital Management first reported a position in LLY in Q4 2021 and held it in 11 quarters. The position peaked at $933K in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

Mendel Capital Management reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
Mendel Capital Management sold 1,031 Eli Lilly shares in Q3 2024, an estimated $933K.
Mendel Capital Management first reported a position in Eli Lilly in Q4 2021 and held it in 11 quarters.
Mendel Capital Management's Eli Lilly position peaked at $933K in Q2 2024.
3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Mendel Capital Management's 13F filing for Q3 2024, filed 7 Nov 2024.